Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Hamilton Thorne Ltd HTLZF

Hamilton Thorne Ltd. is a provider of precision instruments, consumables, software and services to assisted reproductive technologies (ART), research, and cell biology markets. The Company markets its products and services under the Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, Microptic, and Embryotech Laboratories brands. It also provides an array of third-party equipment and... see more

OTCPK:HTLZF - Post Discussion

Hamilton Thorne Ltd > very disappointing stock
View:
Post by Possibleidiot01 on Mar 14, 2024 8:13pm

very disappointing stock

Beginning to wonder if the current U.S political/ legal environment is having a big effect on the stock?

Results have been pretty good with a track record of good accretive acquisitions and there's a whole world of opportunities for more buys. Only one major competitor in the space.

The other problem I can think of is this is an orphan stock in a way - U.S stock trading in Canada ; some people stay from companies that are like this

Anybodyelse got any theories?

Comment by colourama on Mar 16, 2024 8:50pm
Perhaps it is a combination as you say of the current legal environment in the US, and also some FOMO with other stocks seeing a big lift and investors starting to loose patience waiting, which provides opportunity. I think we move up from this level as their next quarterly results should be quite good according to their outlook, and carry over to 2024. Perhaps back to the $1.60 level? Would ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities